Pricing
Login
Home
Charts
Search
Watchlist
Products

Sanofi India Ltd

SANOFI
₹3,206.10+0.11%20 Nov 2026
Reports
Pharma MNC Bulk Drugs

Sanofi India Ltd

SANOFI
₹3,206.10
+0.11%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹7,384Cr
Close
Close Price
₹3,206.10
Industry
Industry
Pharma MNC Bulk Drugs
PE
Price To Earnings
20.26
PS
Price To Sales
4.05
Revenue
Revenue
₹1,822Cr
Rev Gr TTM
Revenue Growth TTM
-5.74%
PAT Gr TTM
PAT Growth TTM
2.30%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
469511464524515536406475420472438492
Growth YoY
Revenue Growth YoY%
-30.2-30.6-10.06.89.74.9-12.3-9.3-18.5-11.97.73.4
Expenses
ExpensesCr
370374348404397364311341330330322331
Operating Profit
Operating ProfitCr
1001371161201181729513490143115161
OPM
OPM%
21.226.825.022.823.032.123.428.221.530.226.332.8
Other Income
Other IncomeCr
9-23-1421439-223466
Interest Expense
Interest ExpenseCr
000000001000
Depreciation
DepreciationCr
999910109910999
PBT
PBTCr
99105921131221659410283138112158
Tax
TaxCr
303324303146252621352941
PAT
PATCr
138137103829112070766210384117
Growth YoY
PAT Growth YoY%
5.2-28.3-15.9-46.0-33.7-12.5-32.8-7.5-32.4-14.120.153.5
NPM
NPM%
29.426.722.315.717.722.317.116.014.721.719.123.7
EPS
EPS₹
59.959.344.935.739.651.930.233.026.844.536.350.7
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
469511464524515536406475420472438492
Growth YoY
Revenue Growth YoY%
-30.2-30.6-10.06.89.74.9-12.3-9.3-18.5-11.97.73.4
Expenses
ExpensesCr
370374348404397364311341330330322331
Operating Profit
Operating ProfitCr
1001371161201181729513490143115161
OPM
OPM%
21.226.825.022.823.032.123.428.221.530.226.332.8
Other Income
Other IncomeCr
9-23-1421439-223466
Interest Expense
Interest ExpenseCr
000000001000
Depreciation
DepreciationCr
999910109910999
PBT
PBTCr
99105921131221659410283138112158
Tax
TaxCr
303324303146252621352941
PAT
PATCr
138137103829112070766210384117
Growth YoY
PAT Growth YoY%
5.2-28.3-15.9-46.0-33.7-12.5-32.8-7.5-32.4-14.120.153.5
NPM
NPM%
29.426.722.315.717.722.317.116.014.721.719.123.7
EPS
EPS₹
59.959.344.935.739.651.930.233.026.844.536.350.7

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025TTM
Revenue
RevenueCr
2,1932,3672,4642,7713,0712,9022,9572,7702,8512,0131,8371,822
Growth
Revenue Growth%
10.97.94.112.510.8-5.51.9-6.32.9-29.4-8.7-5.7
Expenses
ExpensesCr
1,7341,8321,9262,1472,4052,1892,1942,0662,0471,5221,3461,312
Operating Profit
Operating ProfitCr
459535537624665713763704804491491510
OPM
OPM%
20.922.621.822.521.724.625.825.428.224.426.728.0
Other Income
Other IncomeCr
51668190354856420483-21-819
Interest Expense
Interest ExpenseCr
021102222221
Depreciation
DepreciationCr
11311910210310082674240373736
PBT
PBTCr
3974805156106006771,258864846431445491
Tax
TaxCr
159176189229186200313244243118118126
PAT
PATCr
238304326381414478944621603314327365
Growth
PAT Growth%
20.628.07.216.88.815.397.7-34.3-2.8-48.04.12.3
NPM
NPM%
10.812.813.213.713.516.531.922.421.215.617.820.0
EPS
EPS₹
139.6132.3141.7165.5179.8207.4410.1269.5261.9179.5141.8158.3
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025TTM
Revenue
RevenueCr
2,1932,3672,4642,7713,0712,9022,9572,7702,8512,0131,8371,822
Growth
Revenue Growth%
10.97.94.112.510.8-5.51.9-6.32.9-29.4-8.7-5.7
Expenses
ExpensesCr
1,7341,8321,9262,1472,4052,1892,1942,0662,0471,5221,3461,312
Operating Profit
Operating ProfitCr
459535537624665713763704804491491510
OPM
OPM%
20.922.621.822.521.724.625.825.428.224.426.728.0
Other Income
Other IncomeCr
51668190354856420483-21-819
Interest Expense
Interest ExpenseCr
021102222221
Depreciation
DepreciationCr
11311910210310082674240373736
PBT
PBTCr
3974805156106006771,258864846431445491
Tax
TaxCr
159176189229186200313244243118118126
PAT
PATCr
238304326381414478944621603314327365
Growth
PAT Growth%
20.628.07.216.88.815.397.7-34.3-2.8-48.04.12.3
NPM
NPM%
10.812.813.213.713.516.531.922.421.215.617.820.0
EPS
EPS₹
139.6132.3141.7165.5179.8207.4410.1269.5261.9179.5141.8158.3
Sales CAGR
1 Year-9%
3 Years-13%
5 Years-9%
TTM-6%
EBITDA CAGR
1 Year0%
3 Years-11%
5 Years-7%
TTM-2%
PAT CAGR
1 Year4%
3 Years-19%
5 Years-7%
TTM2%
Avg. ROCE
1 Year58%
3 Years63%
5 Years62%
TTM60%
CFO / EBITDA
1 Year89%
3 Years63%
5 Years64%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025Jun 2026
Equity Capital
Equity CapitalCr
232323232323232323232323
Reserves
ReservesCr
1,6041,8602,0032,1962,4192,0962,2031,253993838726803
Current Liabilities
Current LiabilitiesCr
617502602624703687750741651737491570
Non Current Liabilities
Non Current LiabilitiesCr
16115615014199113865548151411
Total Liabilities
Total LiabilitiesCr
2,4052,5412,7782,9843,2442,9193,0612,0721,7151,6121,2551,407
Current Assets
Current AssetsCr
1,2441,5751,4441,5922,1291,8332,1381,6101,2461,127801965
Non Current Assets
Non Current AssetsCr
1,1619661,3341,3921,1151,085923461469485454442
Total Assets
Total AssetsCr
2,4052,5412,7782,9843,2442,9193,0612,0721,7151,6121,2551,407
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025Jun 2026
Equity Capital
Equity CapitalCr
232323232323232323232323
Reserves
ReservesCr
1,6041,8602,0032,1962,4192,0962,2031,253993838726803
Current Liabilities
Current LiabilitiesCr
617502602624703687750741651737491570
Non Current Liabilities
Non Current LiabilitiesCr
16115615014199113865548151411
Total Liabilities
Total LiabilitiesCr
2,4052,5412,7782,9843,2442,9193,0612,0721,7151,6121,2551,407
Current Assets
Current AssetsCr
1,2441,5751,4441,5922,1291,8332,1381,6101,2461,127801965
Non Current Assets
Non Current AssetsCr
1,1619661,3341,3921,1151,085923461469485454442
Total Assets
Total AssetsCr
2,4052,5412,7782,9843,2442,9193,0612,0721,7151,6121,2551,407

Cash Flow

Consolidated
Standalone
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow
Operating Cash FlowCr
213322435374412611559399231462438
Investing Cash Flow
Investing Cash FlowCr
36-155-79-736627663165136-19-11
Financing Cash Flow
Financing Cash FlowCr
-147-180-188-197-183-810-849-1,583-878-392-448
Net Cash Flow
Net Cash FlowCr
102-1316810429578341-533-61250-21
Free Cash Flow
Free Cash FlowCr
185253379317337810574412221426413
CFO To PAT
CFO To PAT%
89.7105.9133.598.299.5128.059.264.238.3147.2134.2
CFO To EBITDA
CFO To EBITDA%
46.460.281.060.062.085.773.356.628.794.189.2
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow
Operating Cash FlowCr
213322435374412611559399231462438
Investing Cash Flow
Investing Cash FlowCr
36-155-79-736627663165136-19-11
Financing Cash Flow
Financing Cash FlowCr
-147-180-188-197-183-810-849-1,583-878-392-448
Net Cash Flow
Net Cash FlowCr
102-1316810429578341-533-61250-21
Free Cash Flow
Free Cash FlowCr
185253379317337810574412221426413
CFO To PAT
CFO To PAT%
89.7105.9133.598.299.5128.059.264.238.3147.2134.2
CFO To EBITDA
CFO To EBITDA%
46.460.281.060.062.085.773.356.628.794.189.2

Ratios

Consolidated
Standalone
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10,0369,89610,85714,63016,15719,15618,17813,47218,57914,0979,4237,384
Price To Earnings
Price To Earnings
31.232.533.338.439.040.119.221.730.834.028.820.3
Price To Sales
Price To Sales
4.64.24.45.35.36.66.24.96.57.05.14.0
Price To Book
Price To Book
6.25.35.36.66.69.08.210.618.316.412.68.9
EV To EBITDA
EV To EBITDA
20.617.418.922.122.625.221.817.722.628.218.713.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
49.150.555.154.252.252.952.853.954.749.149.249.2
OPM
OPM%
20.922.621.822.521.724.625.825.428.224.426.728.0
NPM
NPM%
10.812.813.213.713.516.531.922.421.215.617.820.0
ROCE
ROCE%
24.425.625.427.524.631.756.066.781.949.258.259.6
ROE
ROE%
14.616.216.117.117.022.542.448.659.436.543.644.1
ROA
ROA%
9.912.011.712.812.816.430.930.035.219.526.025.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearDec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10,0369,89610,85714,63016,15719,15618,17813,47218,57914,0979,4237,384
Price To Earnings
Price To Earnings
31.232.533.338.439.040.119.221.730.834.028.820.3
Price To Sales
Price To Sales
4.64.24.45.35.36.66.24.96.57.05.14.0
Price To Book
Price To Book
6.25.35.36.66.69.08.210.618.316.412.68.9
EV To EBITDA
EV To EBITDA
20.617.418.922.122.625.221.817.722.628.218.713.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
49.150.555.154.252.252.952.853.954.749.149.249.2
OPM
OPM%
20.922.621.822.521.724.625.825.428.224.426.728.0
NPM
NPM%
10.812.813.213.713.516.531.922.421.215.617.820.0
ROCE
ROCE%
24.425.625.427.524.631.756.066.781.949.258.259.6
ROE
ROE%
14.616.216.117.117.022.542.448.659.436.543.644.1
ROA
ROA%
9.912.011.712.812.816.430.930.035.219.526.025.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr46,20717,64015,4199,2787,9287,3844,784
Close PriceClose₹2,727.603,856.006,167.505,589.503,442.403,206.101,367.60
IndustryIndustryPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk Drugs
Price To EarningsPE40.8520.5386.7624.4328.3520.26
Price To SalesPS11.116.655.936.228.104.0514.22
RevenueRevenueCr4,1592,6542,6021,4919791,822336
Revenue Growth TTMRev Gr TTM%12.1%11.8%29.7%16.1%22.7%-5.7%-5.2%
PAT Growth TTMPAT Gr TTM%20.0%2.4%-10.8%23.8%28.4%2.3%-103.7%
Market CapitalizationMkt CapCr46,20717,64015,4199,2787,9287,3844,784
Close PriceClose₹2,727.603,856.006,167.505,589.503,442.403,206.101,367.60
IndustryIndustryPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk Drugs
Price To EarningsPE40.8520.5386.7624.4328.3520.26
Price To SalesPS11.116.655.936.228.104.0514.22
RevenueRevenueCr4,1592,6542,6021,4919791,822336
Revenue Growth TTMRev Gr TTM%12.1%11.8%29.7%16.1%22.7%-5.7%-5.2%
PAT Growth TTMPAT Gr TTM%20.0%2.4%-10.8%23.8%28.4%2.3%-103.7%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews